215 related articles for article (PubMed ID: 15650203)
1. The Epstein-Barr virus-encoded LMP2A and LMP2B proteins promote epithelial cell spreading and motility.
Allen MD; Young LS; Dawson CW
J Virol; 2005 Feb; 79(3):1789-802. PubMed ID: 15650203
[TBL] [Abstract][Full Text] [Related]
2. Epstein-barr virus latent membrane protein 2B (LMP2B) modulates LMP2A activity.
Rovedo M; Longnecker R
J Virol; 2007 Jan; 81(1):84-94. PubMed ID: 17035319
[TBL] [Abstract][Full Text] [Related]
3. Latent membrane protein 2B regulates susceptibility to induction of lytic Epstein-Barr virus infection.
Rechsteiner MP; Berger C; Zauner L; Sigrist JA; Weber M; Longnecker R; Bernasconi M; Nadal D
J Virol; 2008 Feb; 82(4):1739-47. PubMed ID: 18057232
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus latent membrane protein-2A induces ITAM/Syk- and Akt-dependent epithelial migration through αv-integrin membrane translocation.
Fotheringham JA; Coalson NE; Raab-Traub N
J Virol; 2012 Oct; 86(19):10308-20. PubMed ID: 22837212
[TBL] [Abstract][Full Text] [Related]
5. The EBV-encoded latent membrane proteins, LMP2A and LMP2B, limit the actions of interferon by targeting interferon receptors for degradation.
Shah KM; Stewart SE; Wei W; Woodman CB; O'Neil JD; Dawson CW; Young LS
Oncogene; 2009 Nov; 28(44):3903-14. PubMed ID: 19718044
[TBL] [Abstract][Full Text] [Related]
6. Epithelial cell adhesion to extracellular matrix proteins induces tyrosine phosphorylation of the Epstein-Barr virus latent membrane protein 2: a role for C-terminal Src kinase.
Scholle F; Longnecker R; Raab-Traub N
J Virol; 1999 Jun; 73(6):4767-75. PubMed ID: 10233937
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus latent membrane protein 2A regulates c-Jun protein through extracellular signal-regulated kinase.
Chen SY; Lu J; Shih YC; Tsai CH
J Virol; 2002 Sep; 76(18):9556-61. PubMed ID: 12186939
[TBL] [Abstract][Full Text] [Related]
8. Latent Membrane Protein 2 (LMP2).
Cen O; Longnecker R
Curr Top Microbiol Immunol; 2015; 391():151-80. PubMed ID: 26428374
[TBL] [Abstract][Full Text] [Related]
9. Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells.
Wasil LR; Wei L; Chang C; Lan L; Shair KH
J Virol; 2015 Aug; 89(15):7612-24. PubMed ID: 25972552
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr Virus Latent Membrane Protein 2A (LMP2A) enhances IL-10 production through the activation of Bruton's tyrosine kinase and STAT3.
Incrocci R; Barse L; Stone A; Vagvala S; Montesano M; Subramaniam V; Swanson-Mungerson M
Virology; 2017 Jan; 500():96-102. PubMed ID: 27792904
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma.
Kong QL; Hu LJ; Cao JY; Huang YJ; Xu LH; Liang Y; Xiong D; Guan S; Guo BH; Mai HQ; Chen QY; Zhang X; Li MZ; Shao JY; Qian CN; Xia YF; Song LB; Zeng YX; Zeng MS
PLoS Pathog; 2010 Jun; 6(6):e1000940. PubMed ID: 20532215
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus latent membrane protein 2 effects on epithelial acinus development reveal distinct requirements for the PY and YEEA motifs.
Fotheringham JA; Raab-Traub N
J Virol; 2013 Dec; 87(24):13803-15. PubMed ID: 24109232
[TBL] [Abstract][Full Text] [Related]
13. Expression of Epstein-Barr virus latent membrane proteins leads to changes in keratinocyte cell adhesion.
Farwell DG; McDougall JK; Coltrera MD
Ann Otol Rhinol Laryngol; 1999 Sep; 108(9):851-9. PubMed ID: 10527275
[TBL] [Abstract][Full Text] [Related]
14. Silencing of latent membrane protein 2B reduces susceptibility to activation of lytic Epstein-Barr virus in Burkitt's lymphoma Akata cells.
Rechsteiner MP; Berger C; Weber M; Sigrist JA; Nadal D; Bernasconi M
J Gen Virol; 2007 May; 88(Pt 5):1454-1459. PubMed ID: 17412973
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt.
Scholle F; Bendt KM; Raab-Traub N
J Virol; 2000 Nov; 74(22):10681-9. PubMed ID: 11044112
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of host kinase activity altered by the LMP2A signalosome-a therapeutic target for Epstein-Barr virus latency and associated disease.
Cooper L; Longnecker R
Antiviral Res; 2002 Dec; 56(3):219-31. PubMed ID: 12406506
[TBL] [Abstract][Full Text] [Related]
17. The effect of Epstein-Barr virus Latent Membrane Protein 2 expression on the kinetics of early B cell infection.
Wasil LR; Tomaszewski MJ; Hoji A; Rowe DT
PLoS One; 2013; 8(1):e54010. PubMed ID: 23308294
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-kappaB transcription factor pathway.
Stewart S; Dawson CW; Takada K; Curnow J; Moody CA; Sixbey JW; Young LS
Proc Natl Acad Sci U S A; 2004 Nov; 101(44):15730-5. PubMed ID: 15498875
[TBL] [Abstract][Full Text] [Related]
19. Syk tyrosine kinase mediates Epstein-Barr virus latent membrane protein 2A-induced cell migration in epithelial cells.
Lu J; Lin WH; Chen SY; Longnecker R; Tsai SC; Chen CL; Tsai CH
J Biol Chem; 2006 Mar; 281(13):8806-14. PubMed ID: 16431925
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus latent membrane protein 2A (LMP2A) employs the SLP-65 signaling module.
Engels N; Merchant M; Pappu R; Chan AC; Longnecker R; Wienands J
J Exp Med; 2001 Aug; 194(3):255-64. PubMed ID: 11489945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
